Drugs that contain Phentermine Hydrochloride; Topiramate

1. Drug name - QSYMIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8895057 VIVUS Escalating dosing regimen for effecting weight loss and treating obesity Jun, 2028

(5 years from now)

US9011906 VIVUS Escalating dosing regimen for effecting weight loss and treating obesity Jun, 2028

(5 years from now)

US9011905 VIVUS Low dose topiramate/phentermine composition and methods of use thereof Jun, 2028

(5 years from now)

US8895058 VIVUS Low dose topiramate/phentermine composition and methods of use thereof Jun, 2028

(5 years from now)

US8580298 VIVUS Low dose topiramate/phentermine composition and methods of use thereof May, 2029

(6 years from now)

US8580299 VIVUS Escalating dosing regimen for effecting weight loss and treating obesity Jun, 2029

(6 years from now)

Treatment: Use of qsymia (phentermine and topiramate) for weight management, including, but not limited to effecting weight loss, treating obesity, and/or treating overweight

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 3.75MG BASE;23MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 7.5MG BASE;46MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 11.25MG BASE;69MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 15MG BASE;92MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.